ARCHIVES

FDA News: Zydelig approved in three B-cell blood cancers

This article is from The Cancer Letter archive.

Vol. 40 No. 31 | August 1, 2014

Download PDF Visit The Full Archive

Related Articles

FASEB: Focus on Research Funding, Not PR

June 14, 2013

Stories On Proscar Cause Confusion In Prostate Cancer Prevention Trial

September 6, 1996

CCOP Review Committees Listed

February 6, 1987

NIH To Fund Fewer Grants This Year, But Reduce Cuts to Individual Awards.

February 8, 2008

Group Chairmen Object To “Directive” Language In Proposed Intergroup Study Guidelines

January 13, 1984

NCI Publishes FOA For Trials Network Program

July 27, 2012